* TapImmune announces phase 2 ovarian cancer trial study
with Astrazeneca/Medimmune and Sloan Kettering Cancer Institute
The post BRIEF-TapImmune announces phase 2 ovarian cancer trial study with Astrazeneca appeared first on NASDAQ.
Forex – financial instrument.Forex news
* TapImmune announces phase 2 ovarian cancer trial study
with Astrazeneca/Medimmune and Sloan Kettering Cancer Institute
The post BRIEF-TapImmune announces phase 2 ovarian cancer trial study with Astrazeneca appeared first on NASDAQ.